Models of Alexander Disease

Myelin Biology and Disorders

Volumn 2, Issue , 2004, Pages 1115-1124

  Messing, Albee ^a   Brenner, Michael ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26444449807     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012439510-7/50099-1     Document Type: Chapter

References (62)

1. Alexander W.S. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 1949, 72:373-381.
2. Amaducci L., Forno K.I., Eng L.F. Glial fibrillary acidic protein in cryogenic lesions of the rat brain. Neurosci. Lett. 1981, 21:27-32.
3. +, hypotonic stress, and cortical spreading depression on astrocyte swelling in GFAP-deficient mice. Glia 2001, 35:189-203.
4. Bignami A., Dahl D. The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and submammalian species. Neuropathol. Appl. Neurobiol. 1976, 2:99-110.
5. Borrett D., Becker L.E. Alexander's disease. A disease of astrocytes. Brain 1985, 108:367-385.
6. Bovolenta P., Liem R.K.H., Mason C.A. Development of cerebellar astroglia: Transitions in form and cytoskeletal content. Dev. Biol. 1984, 102:248-259.
7. Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genet. 2001, 27:117-120.
8. Brenner M., Lampel K., Nakatani Y., Mill J., Banner C., Mearow K., Dohadwala M., Lipsky R., Freese E. Characterization of human cDNA and genomic clones for glial fibrillary acidic protein. Mol. Brain Res. 1990, 7:277-286.
9. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., Sisodia S.S., Rothstein J.D., Borchelt D.R., Price D.L., Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338.
10. Clarke S.R., Shetty A.K., Bradley J.L., Turner D.A. Reactive astrocytes express the embryonic intermediate neurofilament nestin. NeuroReport 1994, 5:1885-1888.
11. Cox N.R., Kwapien R.P., Sorjonen D.C., Braund K.G. Myeloencephalopathy resembling Alexander's disease in a Scottish terrier dog. Acta Neuropathol. (Berl.) 1986, 71:163-166.
12. Dahl D. The vimentin-GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J. Neurosci. Res. 1981, 6:741-748.
13. Dahl D., Bignami A., Weber K., Osborn M. Filament proteins in rat optic nerves undergoing Wallerian degeneration: Localization of vimentin, the fibroblastic 100- filament protein, in normal and reactive astrocytes. Exp. Neurol. 1981, 73:496-506.
14. Eddleston M., Mucke L. Molecular profile of reactive astrocytes Implications for their role in neurologic disease. Neuroscience 1993, 54:15-36.
15. Eliasson C., Sahlgren C., Berthold C.H., Stakeberg J., Celis J.E., Betsholtz C., Eriksson J.E., Pekny M. Intermediate filament protein partnership in astrocytes. J. Biol. Chem. 1999, 274:23996-24006.
16. Eng L.F., Lee Y.L. Intermediate filaments in astrocytes. Neuroglial Cells 1993, Oxford University Press, New York. B.R. Ransom, H. Kettenmann (Eds.).
17. Eng L.F., Lee Y.L., Kwan H., Brenner M., Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J. Neurosci. Res. 1998, 53:353-360.
18. Fankhauser R., Fatzer R., Bestetti G., Deruaz J.P., Perentes E. Encephalopathy with Rosenthal fibre formation in a sheep. Acta Neuropathol. (Berl.) 1980, 50:57-60.
19. Frisén J., Johansson C.B., Török C., Risling M., Lendahl U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J. Cell Biol. 1995, 131:453-464.
20. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science 1998, 279:514-519.
21. Gomi H., Yokoyama T., Fujimoto K., Ideka T., Katoh A., Itoh T., Itohara S. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron 1995, 14:29-41.
22. Hatten M.E., Liem R.K.H., Shelanski M.L., Mason C.A. Astroglia in CNS injury. Glia 1991, 4:233-243.
23. Head M.W., Goldman J.E. Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathology & Applied Neurobiology 2000, 26:304-312.
24. Herndon R.M. Is Alexander's disease a nosologic entity or a common pathologic pattern of diverse etiology?. Journal of Child Neurology 1999, 14:275-276.
25. Herndon R.M., Rubinstein L.J., Freeman J.M., Mathieson G. Light and electron microscopic observations on Rosenthal fibers in Alexander's disease and in multiple sclerosis. J. Neuropathol. Exp. Neurol. 1970, 29:524-551.
26. Iwaki T., Kume-Iwaki A., Liem R.K.H., Goldman J.E. αB-Crystallin is expressed in non-lenticular tissues and accumulates in Alexander disease brain. Cell 1989, 57:71-78.
27. Johnson D.A., Andrews G.K., Xu W., Johnson J.A. Activation of the antioxidant responsive element in primary cortical neuronal cultures derived from transgenic reporter mice. J. Neurochem. 2002, 81:1233-1241.
28. Kato S., Hayashi H., Nakashima K., Nanba E., Kato M., Hirano A., Nakano I., Asayama K., Ohama E. Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am. J. Pathol 1997, 151:611-620.
29. Kato S., Shimoda M., Watanabe Y., Nakashima K., Takahashi K., Ohama E. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: Multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J. Neuropathol. Exp. Neurol. 1996, 55:1089-1101.
30. Koyama Y., Goldman J.E. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by αB-crystallin. Am. J. Pathol. 1999, 154:1563-1572.
31. Li R., Messing A., Goldman J.E., Brenner M. GFAP mutations in Alexander disease. Int. J. Dev. Neurosci. 2002, 20:259-268.
32. Liedtke W., Edelmann W., Bieri P.L., Chiu F.C., Cowan N.J., Kucherlapati R., Raine C.S. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996, 17:607-615.
33. Liedtke W., Edelmann W., Chiu F.-C., Kucherlapati R., Raine C.S. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am. J. Pathol. 1998, 152:251-259.
34. Lupski J.R., Montes de Oca-Luna R., Slaugenhaupt S., Pentao L., Guzzetta V., Trask B.J., Saucedo-Cardenas O., Barker D.F., Killian J.M., Garcia C.A., Chakravarti A., Patel P.I. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991, 66:219-232.
35. Mathewson A.J., Berry M. Observations on the astrocyte response to a cerebral stab wound in adult rats. Brain Res. 1985, 327:61-69.
36. McCall M.A., Gregg R.G., Behringer R.R., Brenner M., Delaney C.L., Galbreath E.J., Zhang C.L., Pearce R.A., Chiu S.Y., Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. USA 1996, 93:6361-6366.
37. McGrath J.T. Fibrinoid leukodystrophy (Alexander's disease). Spontaneous Animal Models of Human Disease 1980, Vol. 2:147-148. Academic Press, New York. E.J. Andrews, B.C. Ward, H.N. Altman (Eds.).
38. Menet V., Ribotta M.G.Y., Chauvet N., Drain M.J., Lannoy J., Colucci-Guyon E., Privat A. Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J. Neurosci. 2001, 21:6147-6158.
39. Messing A., Head M.W., Galles K., Galbreath E.J., Goldman J.E., Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am. J. Pathol. 1998, 152:391-398.
40. Nawashiro H., Brenner M., Fukui S., Shima K., Hallenbeck J.M. High susceptibility to cerebral ischemia in GFAP-null mice. Journal of Cerebral Blood Flow & Metabolism 2000, 20:1040-1044.
41. Nawashiro H., Messing A., Azzam N., Brenner M. Mice lacking glial fibrillary acidic protein are hypersensitive to traumatic cerebrospinal injury. NeuroReport 1998, 9:1691-1696.
42. Ni Q., Johns G.S., Manepalli A., Martin D.S., Geller T.J. Infantile Alexander's disease: Serial neuroradiologic findings. J. Child Neurol. 2002, 17:463-466.
43. Nicholl I.D., Quinlan R.A. Chaperone activity of α-crystallins modulates intermediate filament assembly. EMBO J. 1994, 13:945-953.
44. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallen A., Perlmann T., Lendahl U., Betsholtz C., Berthold C.H., Frisen J. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J. Cell Biol. 1999, 145:503-514.
45. Pekny M., Levéen P., Pekna M., Eliasson C., Berthold C.-H., Westermark B., Betsholtz C. Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J. 1995, 14:1590-1598.
46. Pekny M., Stanness K.A., Eliasson C., Betsholtz C., Janigro D. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice. Glia 1998, 22:390-400.
47. Pixley S.K.R., de Vellis J. Transition between immature radial glia and mature astrocytes studied with a monoclonal antibody to vimentin. Dev. Brain Res. 1984, 15:201-209.
48. Reichelt J., Bussow H., Grund C., Magin T.M. Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Molecular Biology of the Cell 2001, 12:1557-1568.
49. Richardson J.A., Tang K., Burns D.K. Myeloencephalopathy with Rosenthal fiber formation in a miniature poodle. Vet. Pathol. 1991, 28:536-538.
50. Rosenthal W. Über eine eigenthümliche, mit syringomyelie complicirte geschwulst des rückenmarks. Bietr. Pathol. Anat. 1898, 23:111-143.
51. Russo L.S., Aron A., Anderson P.J. Alexander's disease: A report and reappraisal. Neurology 1976, 26:607-614.
52. Rutka J.T., Smith S.L. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: Analysis of expression, proliferation, and tumorigenicity. Cancer Res. 1993, 53:3624-3631.
53. Sherwin R.M., Berthrong M. Alexander's disease with sudanophilic leukodystrophy. Archives of Pathology & Laboratory Medicine 1970, 89:321-328.
54. Shibuki K., Gomi H., Chen L., Bao S.W., Kim J.S.K., Wakatsuki H., Fujisaki T., Fujimoto J., Katoh A., Ikeda T., Chen C., Thompson R.F., Itohara S. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 1996, 16:587-599.
55. Sistermans E.A., Decoo R.F.M., Dewijs I.J., Vanoost B.A. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology 1998, 50:1749-1754.
56. Takemura M., Nishiyama H., Itohara S. Distribution of phosphorylated glial fibrillary acidic protein in the mouse central nervous system. Genes to Cells 2002, 7:295-307.
57. Tanaka H., Katoh A., Oguro K., Shimazaki K., Gomi H., Itohara S., Masuzawa T., Kawai N. Disturbance of hippocampal long-term potentiation after transient ischemia in GFAP deficient mice. J. Neurosci. Res. 2002, 67:11-20.
58. Tatzelt J., Maeda N., Pekny M., Yang S.L., Betsholtz C., Eliasson C., Cayetano J., Camerino A.P., DeArmond S.J., Prusiner S.B. Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein. Neurology 1996, 47:449-453.
59. Wahlsten D. Deficiency of corpus callosum varies with strain and supplier of the mice. Brain Res. 1982, 239:329-347.
60. Wang X., Messing A., David S. Axonal and non-neuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Exp. Neurol. 1997, 148:568-576.
61. Weinstein D.E., Shelanski M.L., Liem R.K.H. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 1991, 112:1205-1213.
62. Weissenböck H., Obermaier G., Dahme E. Alexander's disease in a Bernese mountain dog. Acta Neuropathol. (Berl.) 1996, 91:200-204.